Risk Factors for the Development of Malignant Melanoma—I: Review of Case‐Control Studies

The Journal of Dermatologic Surgery and Oncology

Volumn 14, Issue 4, 1988, Pages 393-408

  EVANS, ROBIN D ^a   KOPF, ALFRED W ^b   LEW, ROBERT A ^c   RIGEL, DARRELL S ^b   BART, ROBERT S ^b   FRIEDMAN, ROBERT J ^b   RIVERS, JASON K ^b  

^a MONTEFIORE MEDICAL CENTER   (United States)

^b NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASE CONTROL STUDY; CONTROLLED STUDY; EYE COLOR; FEMALE; HAIR COLOR; HUMAN; LENTIGO; MALE; MELANOMA; NEVUS; REVIEW; SOCIAL STATUS; SUNLIGHT;

HUMAN; MELANOMA; RISK FACTORS; SKIN NEOPLASMS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023939604     PISSN: 01480812     EISSN: 15244725     Source Type: Journal    
DOI: 10.1111/j.1524-4725.1988.tb03373.x     Document Type: Review

References (69)

1. Malignant melanoma incidence at the Los Alamos National Laboratory
2. A case‐control study of the possible association between oral contraceptives and malignant melanoma
3. Diazepam and malignant melanoma
4. Malignant melanoma among employees of Lawrence Liver‐more National Laboratory
5. Melanoma after exposure to PCB's
6. Oral contraceptive use and malignant melanoma
7. Further evidence for increased light sensitivity in patients with malignant melanoma
8. Malignant melanoma and oral contraceptive use among women in California
9. Malignant melanoma and exposure to fluorescent lighting at work
10. Cutaneous factors related to the risk of malignant melanoma
11. Oral contraceptive use and malignant melanoma in Australia
12. Confidence intervals
13. Racial differences in melanoma incidence
14. Variation of melanoma incidence with latitude in North America and Europe
15. Epidemiology of malignant melanoma: Pigmentary traits, ultraviolet radiation, and the identification of high‐risk populations
16. A genetic analysis of melanoma—Polygenic inheritance as a threshold trait
17. Pigmentation and skin reaction to sun as risk factors for cutaneous melanoma: Western Canada melanoma study
18. Sunburn, suntan and the risk of cutaneous malignant melanoma—The Western Canada Melanoma Study
19. Cutaneous melanoma in relation to intermittent and constant sun exposure—The Western Canada melanoma study
20. Malignant melanoma in relation to moles, pigmentation, and exposure to fluorescent and other lighting sources
21. Cutaneous malignant melanoma and fluorescent lighting
22. Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada melanoma study
23. Risk factors for cutaneous malignant melanoma: The Western Canada Melanoma Study
24. An inquiry into the epidemiology of melanoma
25. Sun exposure and the risk of melanoma
26. Common acquired naevi and the risk of malignant melanoma
27. Sunburn and malignant melanoma
28. Cutaneous malignant melanoma in association with other skin cancers
29. Hormonal factors and melanoma in women
30. Risk factors for cutaneous melanoma in Queensland
31. High risk of malignant melanoma‐prone families with dysplastic nevi
32. Correcting for variable age of onset in the estimation of familial relative risk when there is a secular trend in incidence of disease
33. Incidence of cancer among vinyl chloride and polyvinyl chloride workers
34. Lack of an elevated risk of malignant melanoma in relation to oral contraceptive use
35. Life‐style factors among patients with melanoma
36. Cutaneous melanoma in relation to exogenous hormones and reproductive factors
37. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: An analysis separating histogenetic types
38. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma
39. Cutaneous malignant melanoma in women: Exogenous sex hormones and reproductive factors
40. The determinants of actinic skin damage: Problems of confounding among environmental and constitutional variables
41. Relationship of solar keratosis and history of skin cancer to objective measures of actinic skin damage
42. Relationship of cutaneous malignant melanoma to individual sunlight‐exposure habits
43. The causes of malignant melanoma: Results from the West Australian Lions Melanoma Research Project
44. Some environmental and bodily characteristics of melanoma patients
45. Prevalence of nevocytic nevi on lateral and medial aspects of arms
46. Sun and malignant melanoma
47. Congenital‐nevus‐like nevi, nevi spili, and cafe‐au‐lait spots in patients with malignant melanoma
48. Relationship of nevocytic nevi to sun exposure in dysplastic nevi
49. Relationship of lumbosacral nevocytic nevi to sun exposure in dysplastic nevus syndrome
50. DNA repair protects against cutaneous and internal neoplasia: Evidence from xeroderma pigmentosum
51. Immunology and photocarcinogenesis
52. Sun exposure habits in patients with cutaneous melanoma: A case control study
53. Dietary polyunsaturated fats and malignant melanoma
54. Severe sunburn and subsequent risk of primary cutaneous malignant melanoma in Scotland
55. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects
56. Malignant melanoma and exposure to fluorescent lighting at work
57. The incidence of malignant melanoma (0 to 15 years of age) arising in “large” congenital nevocellular nevi
58. Relationship of fluorescent lights to malignant melanoma: Another view
59. The rate of malignant melanoma in the U.S.: Are we making an impact
60. The aetiological significance of sunlight and fluorescent lighting in malignant melanoma: A case‐control study
61. Benign naevi associated with high risk of melanoma
62. Incidence of cancer in the electronics industry: Using the new Swedish cancer environment registry as a screening instrument
63. Evaluation of the risk of multiple primaries in malignant cutaneous melanoma
64. Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: Interview study from the Third National Cancer Survey